Neurol. praxi. 2011;12(1):22-25

Myoklonus

MUDr.Marek Baláž, Ph.D., MUDr.Martina Bočková
Centrum pro abnormní pohyby a parkinsonizmus, I. neurologická klinika, LF MU a FN u sv. Anny, Brno

Myoclonus is a fast, jerky involuntary movement caused by a muscle contraction or inhibition. It is classified according to the clinical characteristics,

anatomical origin or its etiology. Myoclonus is either physiological or it can be a symptom of various neurological disorders.

Neurophysiological diagnostics is widely used, besides history and meticulous clinical examination. Therapy is empirical, with clonazepam

as one of the most often administered drugs. It appears that the combination therapy with several drugs is more successful.

Keywords: myoclonus, classification, differential diagnostics

Published: February 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Baláž M, Bočková M. Myoklonus. Neurol. praxi. 2011;12(1):22-25.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bareš M, Muchová M, Kaňovský P, Rektor I. Myoklonus - srovnání účinnosti léčby podle typu ovlivněných neurotransmiterových systémů. Neurol. pro praxi 2006; 1: 43-45.
    2. Brown P, Ridding MC, Werhahn KJ, Rothwell JC, Marsden CD. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain. 1996; 119(Pt 1): 309-317. Go to original source... Go to PubMed...
    3. Borg M. Symptomatic myoclonus. Neurophysiol Clin. 2006; 36(5-6): 309-318. Go to original source... Go to PubMed...
    4. Caviness JN, Alving LI, Maraganore DM, Black RA, McDonnell SK, Rocca WA. The incidence and prevalence of myoclonus in Olmsted County, Minnesota. Mayo Clin Proc 1999; 74(6): 565-569. Go to original source... Go to PubMed...
    5. Caviness JN, Truong DD. Myoclonus. In: International Neurology: A Clinical Approach. Lisak RP, Truong DD, Caroll WM, Bhidayasiri R (eds) Wiley Blackwell, Chichester 2009: 179-183. Go to original source...
    6. Capelle HH, Wöhrle JC, Weigel R, Grips E, Bäzner HJ, Krauss JK. Propriospinal myoclonus due to cervical disc herniation. Case report. J Neurosurg Spine. 2005; 2(5): 608-611. Go to original source... Go to PubMed...
    7. Daniel DG, Webster DL. Spinal segmental myoclonus. Successful treatment with cervical spinal decompression. Arch Neurol 1984; 41: 898-899. Go to original source... Go to PubMed...
    8. Deuschl G, Toro C, Valls-Solé J, Zeffiro T, Zee DS, Hallett M. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994; 117(Pt 4): 775-788. Go to original source... Go to PubMed...
    9. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995; 59(4): 406-412. Go to original source... Go to PubMed...
    10. Fahn S, Overview, history and classification of myoclonus. In Fahn S, Frucht SJ, Hallet M, Truong DD (eds): Myoclonus and Paroxysmal Dyskinesias. Advances in Neurology, vol 89. Philadelphia, Lippincott Williams & Wilkins, 2002: 13-17.
    11. Fahn S, Jankovic J. Myoclonus. Phenomenology, Etiology, Physiology, and Treatment. In Fahn S, Jankovic J (eds): Principles and Practice of Movement Disorders. Philadelphia. Churchill, Livingston, Elsevier 2007: 519-540. Go to original source...
    12. Gelisse P, Crespel A, Genton P, Baldy-Moulinier M. Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol Scand. 2003; 107(4): 302-303. Go to original source... Go to PubMed...
    13. Gruber D, Kühn AA, Schoenecker T, Kivi A, Trottenberg T, Hoffmann KT, Gharabaghi A, Kopp UA, Schneider GH, Klein C, Asmus F, Kupsch A. Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord. 2010; 25(11): 1733-1743. Go to original source... Go to PubMed...
    14. Hallett M, Chadwick D, Marsden CD. Ballistic movement overflow myoclonus a form of essential myoclonus. Brain. 1977; 100(2): 299-312. Go to original source... Go to PubMed...
    15. Jech R. Myoklonus a jeho diferenciální diagnostika. Postgraduální medicína 2006; 8, 5: 523-528.
    16. de Koning-Tijsen MAJ, Tijsen CC. Myoclonus. In: Wolters Ech, van Laar T, Berendse HW (eds). Parkinsonism and Related Disorders. Amsterdam, VU University Press, 2007: 381-400.
    17. Lapresle J. Palatal myoclonus. Adv Neurol. 1986; 43: 265-273.
    18. Monday M, Jankovic J. Psychogenic myoclonus Neurology 1993; 43: 349-352.
    19. Obeso JA, Rothwell JC, Marsden CD. The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain. 1985; 108(Pt 1): 193-124. Go to original source... Go to PubMed...
    20. Obeso JA, Artieda J, Rothwell JC, Day B, Thompson P, Marsden CD. The treatment of severe action myoclonus. Brain. 1989; 112(Pt 3): 765-777. Go to original source... Go to PubMed...
    21. Obeso JA, Artieda J, Burleigh A Adv Neurol. 1995; 67: 1-7. Clinical aspects of negative myoclonus. Go to PubMed...
    22. Rektor I, Kadaňka Z, Bednařík J. Reflex reticular myoclonus. Acta Neurol Scand 1991; 83: 221-225. Go to original source... Go to PubMed...
    23. Rektor I. Myoklonus. Česká a slovenská neurologie a neurochirurgie, Ročník 63/96, Supplementum I, 2000: 2-19.
    24. Shprecher D, Silberstein H, Kurlan R. Propriospinal myoclonus due to cord compresson in the absence of myelopathy. Movement Disorders 2010; 25: 1100-1101. Go to original source... Go to PubMed...
    25. Swanson PD, Luttrell CN, Magladery JW. Myoclonus - a report of 67 cases and review of the literature.Medicine (Baltimore). 1962; 41: 339-356. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.